Camp4 Therapeutics (CAMP) Operating Leases (2023 - 2026)

Camp4 Therapeutics has disclosed Operating Leases across 4 years of filings, most recently posting $1.7 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $1.7 million, down 63.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 63.02% YoY), and the FY2025 annual result was $1.7 million, down 69.27% from the prior year.
• Operating Leases came in at $1.7 million for Q1 2026 at Camp4 Therapeutics, up from $1.7 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $8.5 million in Q4 2023 to a low of $1.7 million in Q4 2025.
• The 4-year median for Operating Leases is $5.1 million (2024), against an average of $4.8 million.
• Across the five-year window, Operating Leases sank 35.28% in 2024 and sank 69.27% in 2025, its largest moves.
• Camp4 Therapeutics' Operating Leases stood at $8.5 million in 2023, then plunged by 35.28% to $5.5 million in 2024, then tumbled by 69.27% to $1.7 million in 2025, then advanced by 2.96% to $1.7 million in 2026.
• The last three Operating Leases figures came in at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.